These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Background Poor adherence to oral antipsychotics is common in patients with
schizophrenia; nonetheless, there has been no systematic review or meta-analysis on …

Background Despite a wealth of studies seeking to identify factors associated with
nonadherence few consistent predictors have been determined, and several gaps still exist …

Background To date, there have been no studies evaluating adherence to clozapine with
electronic adherence monitoring (EAM) such as the Medication Event Monitoring System …

Background Poor adherence to long-term recombinant human growth hormone (r-hGH)
treatment can lead to suboptimal clinical outcomes; consequently, supporting and …

Introduction In a previous review, spanning 3 decades, we found that self-report and other
non-objective measures were the primary means of assessing adherence to oral …

Aims The purpose of this study is to provide a theoretical framework for the analysis of
medication adherence based on longitudinal data from electronic medication monitors and …

Medication nonadherence is common and results in avoidable morbidity, mortality, and
burdens on healthcare systems. This paper proposes a preventative approach to medication …

Objectives Suboptimal medication adherence is a serious problem in the treatment of
chronic inflammatory diseases. To measure medication adherence, electronic monitoring is …

Poor medication adherence remains frequent in schizophrenia. The present study examined
the efficacy of two month-long pilot interventions using the Medication Event Monitoring …